Prophylaxis with aspirin should be consideredBMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6985.1008b (Published 15 April 1995) Cite this as: BMJ 1995;310:1008
- K T Moriarty
- Honorary clinical assistant Diabetes Unit, Queen's Medical Centre, Nottingham NG7 2UH
EDITOR,—Helen Ward and John S Yudkin have found no evidence that thrombolysis increases the risk of haemorrhage from retinopathy.1 This will increase doctors' confidence in choosing whether to use thrombolytic drugs for myocardial infarction in patients with diabetes. But the argument that prevented use of these drugs in people at risk of vitreous haemorrhage has always been flawed. Vitreous haemorrhage usually causes transient blindness, indicating that there is proliferative retinopathy that needs treatment. Laser treatment and, if necessary, vitrectomy are extremely effective in preventing further vitreous …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial